Short answer
Biohaven Ltd. (BHVN) filed an 8-K current report with the SEC on August 7, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). John Yetimoglu appointed director effective August 6, 2026, with term expiring at 2027 annual meeting.
Biohaven Ltd. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- John Yetimoglu appointed director effective August 6, 2026, with term expiring at 2027 annual meeting
- Added to Nominating and Governance Committee, strengthening board oversight and governance capacity
- Non-employee director option award valued at $713,875, vesting 25% at grant and quarterly over three anniversaries
- $57,000 annual retainer increases ongoing director compensation obligations
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Biohaven Ltd. 8-K filings
Get the next BHVN 8-K as it lands
Follow BHVN for push alerts, or ask the research agent what this filing means.